Dr PreZiGen

For biopharma companies

Move biomarker science into clinical adoption.

Connect evidence, expert education and public understanding to support responsible biomarker-led cancer care across the adoption pathway.

Explore the approach Explore a partnership
Abstract illustration of a DNA double helix connected to a network of cells

AI intelligence × Human judgement

Evidence-linked · Patient-specific · Expert-reviewed

From complexity to clarity

What arrives fragmented…

  • Rapid approval landscape
  • Testing-access gaps
  • Adoption barriers
  • Public-awareness deficit

Dr PreZiGen AI–HI

An evidence-led partnership from biomarker strategy to adoption.

Clinical context × Evidence synthesis × Expert review

What you receive

Evidence-led programmes, independently delivered

Biomarker strategy

Map testing pathways, evidence gaps and stakeholder barriers by tumour type.

Continuing medical education

Independent programmes for oncologists, pathologists and multidisciplinary teams.

Patient-awareness initiatives

Responsible education that replaces misinformation with informed hope.
Educational programmes are developed with editorial independence and in line with applicable regulations and codes of practice. We do not promote specific products to patients.

Secure case workflow

Explore a biopharma partnership

Therapeutic area · Biomarker · Geography · Stakeholder objective

Secure · Partnership enquiries need no patient data.

Start an enquiry

Dr PreZiGen · Sample interpretation format

Dr PreZiGen De-identified example

Precision oncology snapshot

Integrated molecular interpretation

Clinical question

Which molecular findings are clinically relevant, and what additional evidence should inform the next discussion with the treating team?

Evidence-linked considerations

  • Established
  • Alternative
  • Clinical trial
  • Further testing
Expert review & sign-off — discussed with the treating team
Illustrative, de-identified example — not a treatment recommendation.

Biopharma partnerships

Tell us about your objective

Share your therapeutic focus and goals. We'll respond to arrange an exploratory conversation; scope and terms are agreed afterwards.

Biopharma partnership enquiry

Please don't share medical records or patient identifiers in this form — clinical documents are only accepted inside the secure portal.

By submitting you agree to our privacy policy.

Voice of experience

Verified patient and clinician experiences will appear here.

We only publish experiences that are genuine, verified and shared with explicit consent.

Coming soon